[Efficacy of botulinum toxin A for the treatment of detrusor hyperreflexia].
Denys P, Even-Schneider A, Thiry Escudie I, Ben Smail D, Ayoub N, Chartier-Kastler E.
Ann Readapt Med Phys. 2003 Jul;46(6):326-8. doi: 10.1016/s0168-6054(03)00113-2.
PMID:12928138
Epidemiology and pathophysiology of neurogenic bladder after spinal cord injury.
Hamid R, Averbeck MA, Chiang H, Garcia A, Al Mousa RT, Oh SJ, Patel A, Plata M, Del Popolo G.
World J Urol. 2018 Oct;36(10):1517-1527. doi: 10.1007/s00345-018-2301-z. Epub 2018 May 11.
PMID:29752515
Importance of pharmacological and physicochemical properties for tolerance of antimuscarinic drugs in the treatment of detrusor instability and detrusor hyperreflexia--chances for improvement of therapy.
Schwantes U, Topfmeier P.
Int J Clin Pharmacol Ther. 1999 May;37(5):209-18.
PMID:10363619
Trospium chloride--an effective drug in the treatment of overactive bladder and detrusor hyperreflexia.
Höfner K, Oelke M, Machtens S, Grünewald V.
World J Urol. 2001 Nov;19(5):336-43. doi: 10.1007/s003450100225.
PMID:11760782
Detrusor hyperreflexia--are there two types?
Lord A, Eastwood H.
Age Ageing. 1994 Jan;23(1):32-3. doi: 10.1093/ageing/23.1.32.
PMID:8010169
Desensitization of bladder sensory fibers by intravesical capsaicin or capsaicin analogs. A new strategy for treatment of urge incontinence in patients with spinal detrusor hyperreflexia or bladder hypersensitivity disorders.
Cruz F.
Int Urogynecol J Pelvic Floor Dysfunct. 1998;9(4):214-20. doi: 10.1007/BF01901607.